738 related articles for article (PubMed ID: 31931284)
1. Dihydrolipoamide dehydrogenase regulates cystine deprivation-induced ferroptosis in head and neck cancer.
Shin D; Lee J; You JH; Kim D; Roh JL
Redox Biol; 2020 Feb; 30():101418. PubMed ID: 31931284
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of Glutaredoxin 5 predisposes Cisplatin-resistant Head and Neck Cancer Cells to Ferroptosis.
Lee J; You JH; Shin D; Roh JL
Theranostics; 2020; 10(17):7775-7786. PubMed ID: 32685019
[No Abstract] [Full Text] [Related]
3. CISD2 inhibition overcomes resistance to sulfasalazine-induced ferroptotic cell death in head and neck cancer.
Kim EH; Shin D; Lee J; Jung AR; Roh JL
Cancer Lett; 2018 Sep; 432():180-190. PubMed ID: 29928961
[TBL] [Abstract][Full Text] [Related]
4. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
Roh JL; Kim EH; Jang HJ; Park JY; Shin D
Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
[TBL] [Abstract][Full Text] [Related]
5. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
6. Nrf2 inhibition reverses resistance to GPX4 inhibitor-induced ferroptosis in head and neck cancer.
Shin D; Kim EH; Lee J; Roh JL
Free Radic Biol Med; 2018 Dec; 129():454-462. PubMed ID: 30339884
[TBL] [Abstract][Full Text] [Related]
7. CISD3 inhibition drives cystine-deprivation induced ferroptosis.
Li Y; Wang X; Huang Z; Zhou Y; Xia J; Hu W; Wang X; Du J; Tong X; Wang Y
Cell Death Dis; 2021 Sep; 12(9):839. PubMed ID: 34497268
[TBL] [Abstract][Full Text] [Related]
8. Poly(rC)-binding protein 1 represses ferritinophagy-mediated ferroptosis in head and neck cancer.
Lee J; You JH; Roh JL
Redox Biol; 2022 May; 51():102276. PubMed ID: 35290903
[TBL] [Abstract][Full Text] [Related]
9. Epigenetic reprogramming of epithelial-mesenchymal transition promotes ferroptosis of head and neck cancer.
Lee J; You JH; Kim MS; Roh JL
Redox Biol; 2020 Oct; 37():101697. PubMed ID: 32896720
[TBL] [Abstract][Full Text] [Related]
10. Role of ferritinophagy in cystine deprivation-induced cell death in glioblastoma cells.
Hayashima K; Kimura I; Katoh H
Biochem Biophys Res Commun; 2021 Feb; 539():56-63. PubMed ID: 33421769
[TBL] [Abstract][Full Text] [Related]
11. Glutaminolysis-related genes determine sensitivity to xCT-targeted therapy in head and neck squamous cell carcinoma.
Okazaki S; Umene K; Yamasaki J; Suina K; Otsuki Y; Yoshikawa M; Minami Y; Masuko T; Kawaguchi S; Nakayama H; Banno K; Aoki D; Saya H; Nagano O
Cancer Sci; 2019 Nov; 110(11):3453-3463. PubMed ID: 31444923
[TBL] [Abstract][Full Text] [Related]
12. Mitochondrial pyruvate carrier 1 regulates ferroptosis in drug-tolerant persister head and neck cancer cells via epithelial-mesenchymal transition.
You JH; Lee J; Roh JL
Cancer Lett; 2021 Jun; 507():40-54. PubMed ID: 33741422
[TBL] [Abstract][Full Text] [Related]
13. Dynasore Blocks Ferroptosis through Combined Modulation of Iron Uptake and Inhibition of Mitochondrial Respiration.
Clemente LP; Rabenau M; Tang S; Stanka J; Cors E; Stroh J; Culmsee C; von Karstedt S
Cells; 2020 Oct; 9(10):. PubMed ID: 33050207
[TBL] [Abstract][Full Text] [Related]
14. Role of Mitochondria in Ferroptosis.
Gao M; Yi J; Zhu J; Minikes AM; Monian P; Thompson CB; Jiang X
Mol Cell; 2019 Jan; 73(2):354-363.e3. PubMed ID: 30581146
[TBL] [Abstract][Full Text] [Related]
15. PGRMC1-dependent lipophagy promotes ferroptosis in paclitaxel-tolerant persister cancer cells.
You JH; Lee J; Roh JL
J Exp Clin Cancer Res; 2021 Nov; 40(1):350. PubMed ID: 34749765
[TBL] [Abstract][Full Text] [Related]
16. Ferroptosis: process and function.
Xie Y; Hou W; Song X; Yu Y; Huang J; Sun X; Kang R; Tang D
Cell Death Differ; 2016 Mar; 23(3):369-79. PubMed ID: 26794443
[TBL] [Abstract][Full Text] [Related]
17. Promotion of ferroptosis in head and neck cancer with divalent metal transporter 1 inhibition or salinomycin.
Lee J; Roh JL
Hum Cell; 2023 May; 36(3):1090-1098. PubMed ID: 36890422
[TBL] [Abstract][Full Text] [Related]
18. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
[TBL] [Abstract][Full Text] [Related]
19. Edaravone, a free radical scavenger, protects against ferroptotic cell death in vitro.
Homma T; Kobayashi S; Sato H; Fujii J
Exp Cell Res; 2019 Nov; 384(1):111592. PubMed ID: 31479686
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of AEBP1 predisposes cisplatin-resistant oral cancer cells to ferroptosis.
Zhou Q; Wang X; Zhang Y; Wang L; Chen Z
BMC Oral Health; 2022 Nov; 22(1):478. PubMed ID: 36352396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
